Imugene only recently dose escalated Vaxinia MAST trial with...

Imugene only recently dose escalated Vaxinia MAST trial with first scans mostly likely showing pseudo progression so I’m guessing the next data cut will come post the next scan or perhaps for the bile duct conference in a few weeks. Why rush the release? Makes more sense to release data when the patients on the highest dose have had enough time on trial to show efficacy. This is potentially the dosage that will make all the difference. Next newsworthy releases could be additional fast track approvals for Pancreatic, Head and Neck and Melanoma plus we could get one more dose escalation.
Any talk of trial failure is pure nonsense given what we have seen already - zero toxicity and serious efficacy at tiny dose levels.
Take a long walk and let team Imugene focus on the important stuff. Enjoy life people.